Last updated on August 2016

Nitrite Isoquercetin and Endothelial Dysfunction (NICE) Trial


Brief description of study

The proposed randomized controlled trial will test the safety and efficacy of combination therapy with sodium nitrite and isoquercetin on endothelial function and inflammation among patients with chronic kidney disease.

Detailed Study Description

The proposed randomized controlled trial will test the safety and efficacy of combination therapy with sodium nitrite and isoquercetin on endothelial function and inflammation among patients with chronic kidney disease. Investigators will recruit 70 albuminuric CKD patients and randomly assign participants to combination therapy with sodium nitrite and isoquercetin or placebo for three months.

Clinical Study Identifier: NCT02552888

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Jing Chen, MD, MS

Tulane School of Medicine
New Orleans, LA United States
  Connect »